| # | Drug | Count |
|---|---|---|
| 0 | CABOTEGRAVIR | 3 |
| 1 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 3 |
| 2 | RALTEGRAVIR | 3 |
| 3 | RILPIVIRINE | 3 |
| 4 | ACETAMINOPHEN | 2 |
| 5 | ACETAMINOPHEN 500MG | 2 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 2 |
| 7 | CABOTEGRAVIR SODIUM | 2 |
| 8 | CIPROFLOXACIN | 2 |
| 9 | CIPROFLOXACIN HYDROCHLORIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 2 | 0.0064 |
| 1 | CABOTEGRAVIR SODIUM | 2 | 0.0012 |
| 2 | RALTEGRAVIR | 3 | 0.0006 |
| 3 | RILPIVIRINE | 3 | 0.0004 |
| 4 | CABOTEGRAVIR | 3 | 0.0004 |
| 5 | ELBASVIR AND GRAZOPREVIR | 1 | 0.0002 |
| 6 | DOLUTEGRAVIR SODIUM | 2 | 0.0002 |
| 7 | ZIDOVUDINE | 2 | 0.0002 |
| 8 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 | 0.0002 |
| 9 | CABOTEGRAVIR AND RILPIVIRINE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0001 |
| 3 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 4 | Macrolide Antimicrobial [EPC] | 2 | 0.0000 |
| 5 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 2 | 0.0000 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Corticosteroid [EPC] | 2 | 0.0000 |